CELADON PHARMACEUTICALS LIMITED

Active London

Manufacture of basic pharmaceutical products

27 employees website.com
Manufacture of basic pharmaceutical products
C

CELADON PHARMACEUTICALS LIMITED

Manufacture of basic pharmaceutical products

Founded 31 Aug 2018 Active London, United Kingdom 27 employees website.com
Manufacture of basic pharmaceutical products

Previous Company Names

CELADON PHARMACEUTICALS PLC 25 Mar 2022 — 14 Aug 2025
SUMMERWAY CAPITAL PLC 31 Aug 2018 — 25 Mar 2022
Accounts Submitted 20 May 2026 Next due 30 Jun 2025 12 months overdue
Confirmation Submitted 21 Oct 2025 Next due 13 Sept 2026 3 months remaining
Net assets £3M £4M 2023 year on year
Total assets £9M £4M 2023 year on year
Total Liabilities £6M £174K 2023 year on year
Charges 3
2 outstanding 1 satisfied

Contact & Details

Contact

Registered Address

71-75 Shelton Street Covent Garden London WC2H 9JQ United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CELADON PHARMACEUTICALS LIMITED (11545912), an active company based in London, United Kingdom. Incorporated 31 Aug 2018. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type group
Next accounts 31 Dec 2024
Due by 30 Jun 2025 12 months overdue

Balance Sheet & P&L (2019–2023)

Cash in Bank

£1.26M

Decreased by £3.80M (-75%)

Net Assets

£3.18M

Decreased by £3.86M (-55%)

Total Liabilities

£6.04M

Decreased by £174.00k (-3%)

Turnover

£149.00k

Increased by £125.00k (+521%)

Employees

27

Increased by 3 (+13%)

Debt Ratio

66%

Increased by 19 (+40%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

16 Allotments 12,775,833 Shares £10.98m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
27 Jan 20266,886£30k£30k
27 Jan 20266,886£30k£30k
17 Sept 20242,625,000£1.05m£0.4
19 Jul 2024238,095£250k£1.05
15 May 20241,285,714£1.35m£1.05

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (9)

James Short
39.5%
Vinodka Murria
29.9%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 3 Ceased

James Gareth Short

British

Active
Notified 28 Mar 2022
Residence England
DOB March 1968
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Mark Kenneth Meakin Farmiloe

Ceased 19 Oct 2018

Ceased

Ian Alexander Anton

Ceased 19 Oct 2018

Ceased

Benjamin Howard Shaw

Ceased 19 Oct 2018

Ceased

Group Structure

Group Structure

CELADON PHARMACEUTICALS LIMITED Current Company
CELADON SUBCO LIMITED united kingdom

Charges

Charges

2 outstanding 1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 May 2026AccountsAnnual accounts made up to 31 Dec 2024
24 Apr 2026CapitalAllotment of shares (GBP 688,576.11) on 23 Apr 2026
14 Apr 2026MortgageMortgage Create With Deed With Charge Number Charge Creation Date
10 Mar 2026MiscellaneousReplacement filing of SH01 - 27/01/26 Statement of Capital gbp 688526.93
17 Feb 2026CapitalAllotment of shares (GBP 688,526.93) on 27 Jan 2026
20 May 2026 Accounts

Annual accounts made up to 31 Dec 2024

24 Apr 2026 Capital

Allotment of shares (GBP 688,576.11) on 23 Apr 2026

14 Apr 2026 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

10 Mar 2026 Miscellaneous

Replacement filing of SH01 - 27/01/26 Statement of Capital gbp 688526.93

17 Feb 2026 Capital

Allotment of shares (GBP 688,526.93) on 27 Jan 2026

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2024

6 days ago on 20 May 2026

Allotment of shares (GBP 688,576.11) on 23 Apr 2026

1 months ago on 24 Apr 2026

Mortgage Create With Deed With Charge Number Charge Creation Date

1 months ago on 14 Apr 2026

Replacement filing of SH01 - 27/01/26 Statement of Capital gbp 688526.93

2 months ago on 10 Mar 2026

Allotment of shares (GBP 688,526.93) on 27 Jan 2026

3 months ago on 17 Feb 2026